Lixte Biotechnology Holdings, INC. (LIXT) — 10-Q Filings

10-Q Filings (6)

• Lixte Biotech's Losses Mount Amidst Strategic Shift & Nasdaq Scrutiny — Nov 12, 2025 Risk: high
  LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported a net loss of $3,465,626 for the nine months ended September 30, 2025, an increase from a net loss of $2,968,271 in
• LIXTE Biotech Remains Pre-Revenue, Faces Funding Hurdles — Aug 7, 2025 Risk: high
  LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported no revenue for the three and six months ended June 30, 2025, consistent with its pre-revenue stage as a pharmaceutic
• Lixte Biotechnology Holdings Q1 2025 10-Q Filing — May 12, 2025 Risk: medium
  LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed its quarterly report for the period ending March 31, 2025. The company, previously known as SRKP 7 INC, is involved in
• LIXTE BIOTECHNOLOGY 10-Q Filing for Q3 2024 — Nov 12, 2024 Risk: medium
  LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed its 10-Q for the period ending September 30, 2024. The filing covers the third quarter and the first nine months of the
• Lixte Biotechnology Holdings Files Q2 2024 10-Q — Aug 8, 2024 Risk: medium
  Lixte Biotechnology Holdings, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the
• LIXTE BIOTECHNOLOGY HOLDINGS, INC. Files 10-Q for Period Ending March 31, 2024 — May 9, 2024 Risk: low
  LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) filed a Quarterly Report (10-Q) with the SEC on May 9, 2024. LIXTE BIOTECHNOLOGY HOLDINGS, INC. filed a 10-Q report fo

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX